Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf16
|
ENSMUSG00000035397.8 | Kruppel-like factor 16 |
Sp8
|
ENSMUSG00000048562.6 | trans-acting transcription factor 8 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_80575936_80576561 | Klf16 | 1073 | 0.268199 | -0.54 | 6.8e-06 | Click! |
chr10_80575689_80575840 | Klf16 | 1557 | 0.177576 | -0.50 | 4.7e-05 | Click! |
chr10_80575271_80575422 | Klf16 | 1975 | 0.140623 | -0.44 | 5.0e-04 | Click! |
chr10_80569864_80570541 | Klf16 | 7119 | 0.077051 | -0.38 | 3.1e-03 | Click! |
chr10_80572443_80572776 | Klf16 | 4712 | 0.084528 | -0.35 | 6.8e-03 | Click! |
chr12_118855278_118855595 | Sp8 | 7850 | 0.223724 | 0.58 | 1.1e-06 | Click! |
chr12_118842631_118843755 | Sp8 | 3136 | 0.282574 | 0.58 | 1.3e-06 | Click! |
chr12_118856123_118856511 | Sp8 | 8731 | 0.220494 | 0.52 | 1.8e-05 | Click! |
chr12_118846102_118846253 | Sp8 | 152 | 0.964391 | 0.44 | 3.9e-04 | Click! |
chr12_118836390_118837564 | Sp8 | 9352 | 0.214056 | 0.44 | 4.0e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_170674573_170675954 | 23.39 |
Asmt |
acetylserotonin O-methyltransferase |
2619 |
0.41 |
chr9_124439879_124441093 | 16.43 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
382 |
0.83 |
chr14_119123052_119124306 | 13.47 |
Hs6st3 |
heparan sulfate 6-O-sulfotransferase 3 |
14662 |
0.18 |
chr14_28508967_28511864 | 12.60 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
203 |
0.89 |
chr5_144357138_144358729 | 12.37 |
Dmrt1i |
Dmrt1 interacting ncRNA |
10 |
0.7 |
chr17_12636042_12637507 | 11.17 |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
15934 |
0.17 |
chr9_64671845_64672188 | 11.13 |
Megf11 |
multiple EGF-like-domains 11 |
11557 |
0.21 |
chr6_30737706_30740349 | 11.01 |
Mest |
mesoderm specific transcript |
972 |
0.4 |
chr9_115216097_115216766 | 10.91 |
Gm27002 |
predicted gene, 27002 |
16033 |
0.15 |
chr3_87947557_87949450 | 10.66 |
Crabp2 |
cellular retinoic acid binding protein II |
163 |
0.9 |
chr13_51594475_51595717 | 10.12 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
25609 |
0.16 |
chr11_108924512_108925408 | 9.79 |
Axin2 |
axin 2 |
1779 |
0.38 |
chr16_21908261_21909020 | 9.26 |
Gm6467 |
predicted gene 6467 |
12134 |
0.14 |
chr17_54297811_54299023 | 9.09 |
Slc5a7 |
solute carrier family 5 (choline transporter), member 7 |
39 |
0.98 |
chr8_121118797_121121438 | 8.94 |
Foxc2 |
forkhead box C2 |
3946 |
0.14 |
chr11_96347886_96350398 | 8.81 |
Hoxb3os |
homeobox B3 and homeobox B2, opposite strand |
1219 |
0.21 |
chr4_126465012_126466992 | 8.75 |
Ago1 |
argonaute RISC catalytic subunit 1 |
2419 |
0.18 |
chr2_74749244_74750558 | 8.73 |
Haglr |
Hoxd antisense growth associated long non-coding RNA |
605 |
0.44 |
chr13_53469792_53470715 | 8.68 |
Msx2 |
msh homeobox 2 |
2821 |
0.27 |
chr7_45785390_45787192 | 8.67 |
Lmtk3 |
lemur tyrosine kinase 3 |
266 |
0.77 |
chr19_10413386_10414587 | 8.66 |
Syt7 |
synaptotagmin VII |
9968 |
0.15 |
chr5_135834823_135835924 | 8.62 |
Gm23268 |
predicted gene, 23268 |
1999 |
0.2 |
chr11_108909583_108911157 | 8.59 |
Axin2 |
axin 2 |
9979 |
0.21 |
chr12_117807954_117808128 | 8.58 |
Cdca7l |
cell division cycle associated 7 like |
3752 |
0.26 |
chr8_84928375_84929627 | 8.55 |
Mast1 |
microtubule associated serine/threonine kinase 1 |
226 |
0.8 |
chr11_107793364_107794626 | 8.52 |
Gm11650 |
predicted gene 11650 |
129 |
0.87 |
chr12_117153278_117156362 | 8.47 |
Gm10421 |
predicted gene 10421 |
3169 |
0.37 |
chr7_29211212_29212428 | 8.37 |
Catsperg1 |
cation channel sperm associated auxiliary subunit gamma 1 |
325 |
0.76 |
chr5_37241461_37244349 | 8.31 |
Crmp1 |
collapsin response mediator protein 1 |
171 |
0.95 |
chr10_103026340_103027824 | 8.22 |
Alx1 |
ALX homeobox 1 |
1545 |
0.39 |
chr5_111701516_111702456 | 8.19 |
Gm26897 |
predicted gene, 26897 |
31938 |
0.15 |
chr3_34662808_34665047 | 8.09 |
Gm42693 |
predicted gene 42693 |
362 |
0.74 |
chr17_93201490_93204144 | 8.00 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
741 |
0.65 |
chr7_139020697_139021233 | 7.95 |
Gm45613 |
predicted gene 45613 |
34 |
0.98 |
chr7_137309191_137310700 | 7.89 |
Ebf3 |
early B cell factor 3 |
3971 |
0.23 |
chr15_98001331_98003530 | 7.87 |
Col2a1 |
collagen, type II, alpha 1 |
543 |
0.74 |
chr11_98601780_98602920 | 7.81 |
Lrrc3c |
leucine rich repeat containing 3C |
4059 |
0.12 |
chr12_75176309_75177605 | 7.79 |
Kcnh5 |
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
375 |
0.92 |
chr9_21204379_21205155 | 7.66 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
8062 |
0.1 |
chr8_108716860_108718878 | 7.57 |
Zfhx3 |
zinc finger homeobox 3 |
3225 |
0.3 |
chr8_122335750_122336915 | 7.56 |
Zfpm1 |
zinc finger protein, multitype 1 |
1701 |
0.24 |
chr19_59457691_59458368 | 7.50 |
Emx2 |
empty spiracles homeobox 2 |
343 |
0.66 |
chr5_75148315_75152589 | 7.47 |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
1840 |
0.2 |
chr10_103027884_103029519 | 7.43 |
Alx1 |
ALX homeobox 1 |
74 |
0.97 |
chr7_29212595_29213829 | 7.43 |
Catsperg1 |
cation channel sperm associated auxiliary subunit gamma 1 |
770 |
0.42 |
chr10_70598201_70600143 | 7.41 |
Phyhipl |
phytanoyl-CoA hydroxylase interacting protein-like |
90 |
0.98 |
chr5_112640559_112641459 | 7.34 |
4933415J04Rik |
RIKEN cDNA 4933415J04 gene |
674 |
0.64 |
chr2_30902329_30903582 | 7.33 |
Ptges |
prostaglandin E synthase |
342 |
0.83 |
chr2_160451237_160452451 | 7.24 |
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) |
84779 |
0.09 |
chr8_89036575_89038609 | 7.20 |
Sall1 |
spalt like transcription factor 1 |
6570 |
0.23 |
chr2_91930544_91931926 | 7.15 |
Mdk |
midkine |
453 |
0.69 |
chr3_8509825_8511666 | 7.12 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr5_135077129_135077753 | 7.09 |
Vps37d |
vacuolar protein sorting 37D |
825 |
0.4 |
chr1_72826047_72827238 | 7.08 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
1320 |
0.5 |
chr5_120321916_120323112 | 7.06 |
Gm42654 |
predicted gene 42654 |
20045 |
0.16 |
chr7_45093013_45094086 | 7.06 |
Rcn3 |
reticulocalbin 3, EF-hand calcium binding domain |
1328 |
0.13 |
chr7_43489310_43490670 | 7.06 |
Iglon5 |
IgLON family member 5 |
85 |
0.92 |
chr17_15544030_15544829 | 7.03 |
Gm18564 |
predicted gene, 18564 |
3387 |
0.13 |
chr14_67236008_67239452 | 6.98 |
Ebf2 |
early B cell factor 2 |
3086 |
0.21 |
chr7_70347472_70349327 | 6.97 |
Gm44948 |
predicted gene 44948 |
703 |
0.54 |
chr7_34798114_34799420 | 6.95 |
Chst8 |
carbohydrate sulfotransferase 8 |
13905 |
0.21 |
chr15_89523769_89524635 | 6.95 |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
120 |
0.84 |
chr5_66675564_66677315 | 6.95 |
Uchl1os |
ubiquitin carboxy-terminal hydrolase L1, opposite strand |
59 |
0.69 |
chr10_77902577_77903608 | 6.93 |
Lrrc3 |
leucine rich repeat containing 3 |
556 |
0.53 |
chr2_33639069_33641423 | 6.78 |
Lmx1b |
LIM homeobox transcription factor 1 beta |
234 |
0.85 |
chr1_72870179_72872445 | 6.75 |
Igfbp5 |
insulin-like growth factor binding protein 5 |
2963 |
0.29 |
chr7_16876015_16876934 | 6.74 |
Dact3 |
dishevelled-binding antagonist of beta-catenin 3 |
1157 |
0.25 |
chr2_66633862_66635239 | 6.69 |
Scn9a |
sodium channel, voltage-gated, type IX, alpha |
103 |
0.98 |
chr6_126163282_126164936 | 6.66 |
Ntf3 |
neurotrophin 3 |
851 |
0.73 |
chrX_106484603_106485985 | 6.66 |
Fndc3c1 |
fibronectin type III domain containing 3C1 |
20 |
0.98 |
chr10_86300220_86301914 | 6.65 |
Timp3 |
tissue inhibitor of metalloproteinase 3 |
511 |
0.83 |
chr5_136881600_136883223 | 6.63 |
Col26a1 |
collagen, type XXVI, alpha 1 |
332 |
0.82 |
chrX_150656320_150657724 | 6.61 |
Tro |
trophinin |
350 |
0.85 |
chr11_52282454_52283691 | 6.58 |
Tcf7 |
transcription factor 7, T cell specific |
259 |
0.89 |
chr11_58238951_58239853 | 6.57 |
Gm5038 |
predicted gene 5038 |
7952 |
0.11 |
chr7_27361048_27362468 | 6.57 |
Gm20479 |
predicted gene 20479 |
4339 |
0.12 |
chr11_42419852_42421693 | 6.52 |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
507 |
0.88 |
chr13_56582551_56582734 | 6.50 |
2010203P06Rik |
RIKEN cDNA 2010203P06 gene |
12895 |
0.17 |
chr11_22006485_22009037 | 6.49 |
Otx1 |
orthodenticle homeobox 1 |
4864 |
0.28 |
chr5_37818003_37820431 | 6.44 |
Msx1 |
msh homeobox 1 |
5365 |
0.21 |
chr5_127227734_127228696 | 6.37 |
Tmem132c |
transmembrane protein 132C |
13593 |
0.18 |
chr8_25520662_25521310 | 6.37 |
Fgfr1 |
fibroblast growth factor receptor 1 |
1149 |
0.37 |
chr5_114024775_114025333 | 6.24 |
Dao |
D-amino acid oxidase |
7962 |
0.13 |
chr7_81991550_81992854 | 6.20 |
Bnc1 |
basonuclin 1 |
105 |
0.63 |
chr2_9882196_9886301 | 6.16 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr8_70787438_70788752 | 6.15 |
Mast3 |
microtubule associated serine/threonine kinase 3 |
2683 |
0.1 |
chr5_37823264_37824531 | 6.11 |
Msx1 |
msh homeobox 1 |
685 |
0.71 |
chr1_136231257_136232167 | 6.10 |
Inava |
innate immunity activator |
1402 |
0.26 |
chr14_48661734_48663217 | 6.07 |
Otx2 |
orthodenticle homeobox 2 |
397 |
0.71 |
chr5_75152837_75154692 | 6.03 |
Gm42802 |
predicted gene 42802 |
111 |
0.58 |
chr11_96251471_96253106 | 6.02 |
Gm53 |
predicted gene 53 |
244 |
0.82 |
chr11_96306504_96308444 | 6.01 |
Hoxb5os |
homeobox B5 and homeobox B6, opposite strand |
564 |
0.48 |
chr2_174760566_174761903 | 5.96 |
Edn3 |
endothelin 3 |
182 |
0.96 |
chr7_142662290_142664788 | 5.96 |
Igf2os |
insulin-like growth factor 2, opposite strand |
1599 |
0.21 |
chr7_24499513_24500150 | 5.94 |
Cadm4 |
cell adhesion molecule 4 |
130 |
0.91 |
chr8_57320946_57324000 | 5.90 |
Hand2os1 |
Hand2, opposite strand 1 |
1245 |
0.3 |
chr19_25505518_25507191 | 5.86 |
Dmrt1 |
doublesex and mab-3 related transcription factor 1 |
647 |
0.72 |
chr17_57069929_57071109 | 5.85 |
Gm49888 |
predicted gene, 49888 |
1159 |
0.21 |
chr6_52226761_52228144 | 5.84 |
Hoxa9 |
homeobox A9 |
82 |
0.89 |
chr2_109677166_109678631 | 5.82 |
Bdnf |
brain derived neurotrophic factor |
866 |
0.48 |
chr12_33955777_33956381 | 5.80 |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
1592 |
0.42 |
chr9_54764594_54766122 | 5.77 |
Crabp1 |
cellular retinoic acid binding protein I |
610 |
0.69 |
chr17_45548830_45550018 | 5.72 |
Tmem151b |
transmembrane protein 151B |
253 |
0.83 |
chr2_180642344_180643352 | 5.72 |
Tcfl5 |
transcription factor-like 5 (basic helix-loop-helix) |
140 |
0.94 |
chr17_68003259_68004568 | 5.71 |
Arhgap28 |
Rho GTPase activating protein 28 |
207 |
0.96 |
chr18_43686487_43688415 | 5.68 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr4_137727380_137728418 | 5.66 |
Rap1gap |
Rap1 GTPase-activating protein |
137 |
0.96 |
chr2_109673568_109674815 | 5.65 |
Bdnf |
brain derived neurotrophic factor |
509 |
0.64 |
chr6_126165403_126167302 | 5.65 |
Ntf3 |
neurotrophin 3 |
363 |
0.92 |
chr2_161498597_161499441 | 5.64 |
Gm29229 |
predicted gene 29229 |
14993 |
0.22 |
chr4_143298537_143299593 | 5.62 |
Pdpn |
podoplanin |
398 |
0.83 |
chr4_91371107_91372322 | 5.62 |
Elavl2 |
ELAV like RNA binding protein 1 |
242 |
0.9 |
chr6_53286898_53288474 | 5.61 |
Creb5 |
cAMP responsive element binding protein 5 |
358 |
0.91 |
chr11_79660249_79661705 | 5.59 |
Rab11fip4 |
RAB11 family interacting protein 4 (class II) |
415 |
0.74 |
chr7_79052729_79053830 | 5.57 |
Gm26633 |
predicted gene, 26633 |
44 |
0.71 |
chr9_106456260_106457377 | 5.57 |
Pcbp4 |
poly(rC) binding protein 4 |
721 |
0.42 |
chr7_45015070_45016591 | 5.53 |
Scaf1 |
SR-related CTD-associated factor 1 |
27 |
0.91 |
chr8_123682285_123682763 | 5.53 |
Rhou |
ras homolog family member U |
28595 |
0.04 |
chr5_128598767_128599033 | 5.52 |
Gm42498 |
predicted gene 42498 |
944 |
0.42 |
chr6_84584705_84586412 | 5.49 |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
2122 |
0.4 |
chr7_29046590_29047055 | 5.49 |
Ryr1 |
ryanodine receptor 1, skeletal muscle |
139 |
0.89 |
chr3_152106774_152107680 | 5.48 |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
195 |
0.8 |
chr4_154635108_154637998 | 5.47 |
Prdm16 |
PR domain containing 16 |
244 |
0.83 |
chr4_22477149_22478263 | 5.46 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
10660 |
0.16 |
chr5_41763315_41764785 | 5.45 |
Nkx3-2 |
NK3 homeobox 2 |
451 |
0.86 |
chr11_120706268_120707653 | 5.43 |
Aspscr1 |
alveolar soft part sarcoma chromosome region, candidate 1 (human) |
1698 |
0.13 |
chr5_117348246_117348568 | 5.42 |
Gm15727 |
predicted gene 15727 |
936 |
0.35 |
chr7_30633440_30635827 | 5.42 |
Etv2 |
ets variant 2 |
1219 |
0.2 |
chr15_95653733_95655035 | 5.41 |
Dbx2 |
developing brain homeobox 2 |
1576 |
0.4 |
chr13_54789087_54790430 | 5.41 |
Tspan17 |
tetraspanin 17 |
113 |
0.94 |
chr14_69767927_69768467 | 5.40 |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
712 |
0.58 |
chr6_127887234_127888691 | 5.39 |
Tspan11 |
tetraspanin 11 |
190 |
0.93 |
chr14_28505401_28506870 | 5.37 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
235 |
0.93 |
chr9_69669605_69671558 | 5.35 |
Gm47203 |
predicted gene, 47203 |
70827 |
0.09 |
chr6_89643866_89645048 | 5.35 |
Txnrd3 |
thioredoxin reductase 3 |
469 |
0.81 |
chr9_53705377_53706662 | 5.33 |
Rab39 |
RAB39, member RAS oncogene family |
213 |
0.91 |
chr8_88603885_88604677 | 5.31 |
Nkd1 |
naked cuticle 1 |
21476 |
0.15 |
chr12_112012861_112013678 | 5.31 |
Tdrd9 |
tudor domain containing 9 |
203 |
0.92 |
chr14_3651660_3652927 | 5.30 |
Gm3020 |
predicted gene 3020 |
263 |
0.87 |
chr14_60086016_60087318 | 5.30 |
Atp8a2 |
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
167 |
0.75 |
chr2_136050884_136052422 | 5.29 |
Lamp5 |
lysosomal-associated membrane protein family, member 5 |
586 |
0.78 |
chr5_119673827_119675890 | 5.28 |
Tbx3 |
T-box 3 |
587 |
0.67 |
chr7_30908216_30909253 | 5.27 |
Mag |
myelin-associated glycoprotein |
5574 |
0.07 |
chr7_121864756_121865960 | 5.25 |
Scnn1b |
sodium channel, nonvoltage-gated 1 beta |
281 |
0.9 |
chr4_139832357_139834219 | 5.25 |
Pax7 |
paired box 7 |
240 |
0.94 |
chr11_108923092_108924343 | 5.24 |
Axin2 |
axin 2 |
536 |
0.8 |
chr14_5148637_5149909 | 5.24 |
Gm3317 |
predicted gene 3317 |
15262 |
0.11 |
chr4_154328569_154328986 | 5.23 |
Prdm16 |
PR domain containing 16 |
6075 |
0.17 |
chr11_32930906_32931403 | 5.22 |
Gm12111 |
predicted gene 12111 |
4994 |
0.19 |
chr11_119558511_119559601 | 5.19 |
Gm11762 |
predicted gene 11762 |
10426 |
0.15 |
chr3_87949543_87950464 | 5.18 |
Crabp2 |
cellular retinoic acid binding protein II |
1337 |
0.25 |
chr17_30635227_30636281 | 5.17 |
Dnah8 |
dynein, axonemal, heavy chain 8 |
2 |
0.96 |
chr15_98003545_98005314 | 5.15 |
Col2a1 |
collagen, type II, alpha 1 |
62 |
0.97 |
chr14_52009953_52011160 | 5.15 |
Zfp219 |
zinc finger protein 219 |
19 |
0.94 |
chr3_31309226_31310664 | 5.14 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
433 |
0.72 |
chr13_83732205_83734272 | 5.13 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr11_85829139_85831432 | 5.12 |
2610027K06Rik |
RIKEN cDNA 2610027K06 gene |
1924 |
0.21 |
chr19_47239858_47241187 | 5.11 |
Neurl1a |
neuralized E3 ubiquitin protein ligase 1A |
11611 |
0.11 |
chr3_131110318_131112630 | 5.10 |
Lef1os1 |
LEF1 opposite strand RNA 1 |
616 |
0.56 |
chr5_112848482_112849121 | 5.09 |
Myo18b |
myosin XVIIIb |
22785 |
0.18 |
chr7_3414859_3415977 | 5.07 |
Gm23450 |
predicted gene, 23450 |
352 |
0.74 |
chr15_101077351_101078497 | 5.06 |
Fignl2 |
fidgetin-like 2 |
643 |
0.63 |
chr10_90828879_90830154 | 5.05 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
50 |
0.97 |
chr2_109693096_109694906 | 5.03 |
Bdnf |
brain derived neurotrophic factor |
408 |
0.85 |
chr17_42315796_42317065 | 5.02 |
Ptchd4 |
patched domain containing 4 |
170 |
0.98 |
chr3_34648572_34651394 | 5.01 |
Sox2 |
SRY (sex determining region Y)-box 2 |
422 |
0.73 |
chr15_85205740_85207341 | 5.01 |
Fbln1 |
fibulin 1 |
535 |
0.78 |
chr1_19215607_19218714 | 5.01 |
Tfap2b |
transcription factor AP-2 beta |
3281 |
0.25 |
chr2_33933933_33934335 | 5.00 |
Gm13403 |
predicted gene 13403 |
7979 |
0.22 |
chr5_36868663_36870303 | 4.96 |
Ppp2r2c |
protein phosphatase 2, regulatory subunit B, gamma |
820 |
0.55 |
chr15_54919454_54921272 | 4.96 |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
238 |
0.93 |
chr7_46179165_46180456 | 4.96 |
Abcc8 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
176 |
0.92 |
chr11_108935468_108935969 | 4.96 |
Axin2 |
axin 2 |
3156 |
0.26 |
chr14_5501278_5502453 | 4.95 |
Gm3488 |
predicted gene, 3488 |
191 |
0.9 |
chr12_3236855_3237648 | 4.95 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
640 |
0.66 |
chr2_107290303_107291116 | 4.95 |
Kcna4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
70 |
0.99 |
chr6_127768524_127769705 | 4.95 |
Prmt8 |
protein arginine N-methyltransferase 8 |
358 |
0.74 |
chr11_105112339_105112903 | 4.94 |
Efcab3 |
EF-hand calcium binding domain 3 |
35 |
0.97 |
chr14_3412245_3413254 | 4.92 |
Gm10409 |
predicted gene 10409 |
135 |
0.93 |
chr4_42184762_42185532 | 4.92 |
1700045I11Rik |
RIKEN cDNA 1700045I11 gene |
14302 |
0.07 |
chr8_57326741_57329467 | 4.90 |
Hand2os1 |
Hand2, opposite strand 1 |
3871 |
0.15 |
chr17_93198991_93201483 | 4.90 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr15_101076799_101077203 | 4.89 |
Fignl2 |
fidgetin-like 2 |
1566 |
0.3 |
chr4_45890093_45890552 | 4.89 |
Ccdc180 |
coiled-coil domain containing 180 |
19 |
0.98 |
chr2_179435486_179435752 | 4.89 |
Cdh4 |
cadherin 4 |
6812 |
0.24 |
chr2_74713881_74716227 | 4.87 |
Hoxd3os1 |
homeobox D3, opposite strand 1 |
942 |
0.23 |
chr2_146834060_146838027 | 4.87 |
Gm14114 |
predicted gene 14114 |
3689 |
0.27 |
chr8_92827121_92828679 | 4.87 |
Mmp2 |
matrix metallopeptidase 2 |
609 |
0.71 |
chr4_153416994_153418184 | 4.86 |
Ajap1 |
adherens junction associated protein 1 |
64590 |
0.14 |
chr4_111719683_111720923 | 4.84 |
Spata6 |
spermatogenesis associated 6 |
98 |
0.98 |
chr2_25304614_25305911 | 4.83 |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
135 |
0.87 |
chr12_103314227_103315511 | 4.81 |
Fam181a |
family with sequence similarity 181, member A |
84 |
0.51 |
chrX_64275723_64277215 | 4.81 |
Slitrk4 |
SLIT and NTRK-like family, member 4 |
510 |
0.87 |
chr11_96292706_96294113 | 4.81 |
Hoxb6 |
homeobox B6 |
933 |
0.29 |
chr1_84695175_84696294 | 4.78 |
Mir5126 |
microRNA 5126 |
105 |
0.73 |
chr8_71654638_71655309 | 4.78 |
Unc13a |
unc-13 homolog A |
3522 |
0.11 |
chr8_90347037_90348254 | 4.77 |
Tox3 |
TOX high mobility group box family member 3 |
481 |
0.89 |
chr12_107977167_107978511 | 4.76 |
Bcl11b |
B cell leukemia/lymphoma 11B |
25575 |
0.24 |
chr1_172025134_172025920 | 4.75 |
Vangl2 |
VANGL planar cell polarity 2 |
1184 |
0.38 |
chr5_32153164_32153923 | 4.74 |
Fosl2 |
fos-like antigen 2 |
7022 |
0.15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.3 | 28.0 | GO:0061642 | chemoattraction of axon(GO:0061642) |
7.6 | 22.8 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
7.1 | 21.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
6.5 | 19.5 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
6.3 | 25.2 | GO:0061205 | paramesonephric duct development(GO:0061205) |
6.2 | 18.5 | GO:0070384 | Harderian gland development(GO:0070384) |
6.1 | 18.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
5.9 | 17.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
5.8 | 17.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
5.8 | 23.0 | GO:0021557 | oculomotor nerve development(GO:0021557) |
5.3 | 10.5 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
5.3 | 10.5 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
5.2 | 20.8 | GO:0007412 | axon target recognition(GO:0007412) |
5.2 | 10.3 | GO:0010159 | specification of organ position(GO:0010159) |
5.0 | 14.9 | GO:0060594 | mammary gland specification(GO:0060594) |
4.9 | 14.6 | GO:0002930 | trabecular meshwork development(GO:0002930) |
4.8 | 14.4 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
4.7 | 9.4 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
4.6 | 13.9 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
4.6 | 18.2 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
4.4 | 17.5 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
4.3 | 17.2 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
4.3 | 12.8 | GO:0048880 | sensory system development(GO:0048880) |
4.2 | 12.6 | GO:0072092 | ureteric bud invasion(GO:0072092) |
4.2 | 12.5 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
4.0 | 44.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
4.0 | 11.9 | GO:0021570 | rhombomere 4 development(GO:0021570) |
3.8 | 7.6 | GO:0007403 | glial cell fate determination(GO:0007403) |
3.7 | 11.1 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
3.6 | 17.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
3.5 | 14.1 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
3.5 | 7.0 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
3.5 | 13.9 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
3.5 | 6.9 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
3.5 | 13.8 | GO:0030035 | microspike assembly(GO:0030035) |
3.4 | 6.8 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
3.4 | 3.4 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
3.3 | 13.3 | GO:0060174 | limb bud formation(GO:0060174) |
3.3 | 13.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
3.3 | 3.3 | GO:0021564 | vagus nerve development(GO:0021564) |
3.3 | 9.8 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
3.2 | 22.7 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
3.2 | 9.7 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
3.2 | 3.2 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
3.1 | 3.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
3.1 | 12.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
3.1 | 9.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
3.1 | 9.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
3.1 | 12.4 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
3.1 | 3.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
3.0 | 15.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
3.0 | 12.0 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
3.0 | 14.9 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
3.0 | 8.9 | GO:0014016 | neuroblast differentiation(GO:0014016) |
2.9 | 5.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
2.9 | 8.7 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.9 | 8.6 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
2.9 | 11.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
2.8 | 11.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
2.8 | 5.7 | GO:0060592 | mammary gland formation(GO:0060592) |
2.8 | 11.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
2.8 | 55.8 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
2.8 | 16.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
2.7 | 8.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
2.7 | 5.4 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
2.7 | 16.1 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
2.7 | 5.3 | GO:0060166 | olfactory pit development(GO:0060166) |
2.6 | 10.5 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
2.6 | 7.7 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
2.5 | 12.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.5 | 10.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
2.5 | 7.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.5 | 7.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
2.5 | 12.4 | GO:0014028 | notochord formation(GO:0014028) |
2.5 | 9.9 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
2.5 | 2.5 | GO:0035799 | ureter maturation(GO:0035799) |
2.5 | 4.9 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
2.4 | 9.8 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
2.4 | 9.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
2.4 | 2.4 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
2.4 | 4.8 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
2.4 | 4.8 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.4 | 7.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
2.3 | 4.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
2.3 | 4.6 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
2.3 | 6.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
2.3 | 11.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
2.3 | 9.1 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
2.3 | 2.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
2.3 | 6.8 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
2.2 | 6.7 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
2.2 | 13.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
2.2 | 15.6 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
2.2 | 8.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
2.2 | 26.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
2.2 | 4.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
2.2 | 6.5 | GO:0021586 | pons maturation(GO:0021586) |
2.2 | 6.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
2.1 | 4.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
2.1 | 8.5 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
2.1 | 8.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
2.1 | 4.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
2.1 | 6.2 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
2.0 | 4.0 | GO:0003266 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
2.0 | 6.0 | GO:0061743 | motor learning(GO:0061743) |
2.0 | 4.0 | GO:0015888 | thiamine transport(GO:0015888) |
2.0 | 10.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
2.0 | 6.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
2.0 | 4.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
2.0 | 4.0 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
2.0 | 7.9 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
2.0 | 5.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
2.0 | 2.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
2.0 | 3.9 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.9 | 1.9 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
1.9 | 1.9 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
1.9 | 1.9 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
1.9 | 3.9 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
1.9 | 5.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.9 | 21.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.9 | 15.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.9 | 3.8 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.9 | 5.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.9 | 5.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.9 | 5.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.9 | 3.7 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.9 | 3.7 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.9 | 14.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.9 | 3.7 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
1.9 | 3.7 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.9 | 5.6 | GO:0030421 | defecation(GO:0030421) |
1.8 | 5.5 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
1.8 | 9.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.8 | 7.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.8 | 7.3 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
1.8 | 12.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.8 | 16.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.8 | 5.4 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
1.8 | 1.8 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.8 | 8.9 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.8 | 5.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.8 | 5.4 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
1.8 | 5.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.8 | 1.8 | GO:0090427 | activation of meiosis(GO:0090427) |
1.7 | 10.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.7 | 1.7 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
1.7 | 3.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.7 | 15.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.7 | 1.7 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
1.7 | 5.2 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
1.7 | 3.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.7 | 8.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.7 | 3.4 | GO:0014029 | neural crest formation(GO:0014029) |
1.7 | 11.8 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
1.7 | 1.7 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
1.7 | 5.0 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.6 | 9.9 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
1.6 | 1.6 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
1.6 | 1.6 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
1.6 | 3.2 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
1.6 | 6.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.6 | 3.2 | GO:0001757 | somite specification(GO:0001757) |
1.6 | 1.6 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.6 | 3.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.6 | 3.1 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
1.5 | 3.1 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.5 | 10.8 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
1.5 | 6.1 | GO:0048664 | neuron fate determination(GO:0048664) |
1.5 | 3.0 | GO:0043584 | nose development(GO:0043584) |
1.5 | 3.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.5 | 4.5 | GO:0033058 | directional locomotion(GO:0033058) |
1.5 | 1.5 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.5 | 1.5 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.5 | 3.0 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.5 | 5.9 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
1.5 | 76.8 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
1.5 | 2.9 | GO:0021843 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
1.5 | 7.3 | GO:0015884 | folic acid transport(GO:0015884) |
1.4 | 7.2 | GO:0046958 | nonassociative learning(GO:0046958) |
1.4 | 8.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.4 | 4.3 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
1.4 | 1.4 | GO:0050957 | equilibrioception(GO:0050957) |
1.4 | 7.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
1.4 | 2.8 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
1.4 | 2.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.4 | 4.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.4 | 4.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.4 | 1.4 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
1.4 | 11.0 | GO:0021854 | hypothalamus development(GO:0021854) |
1.4 | 2.7 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.4 | 10.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.4 | 2.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.3 | 20.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
1.3 | 6.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.3 | 2.7 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.3 | 8.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.3 | 6.6 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.3 | 4.0 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
1.3 | 11.9 | GO:0021884 | forebrain neuron development(GO:0021884) |
1.3 | 3.9 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.3 | 6.5 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
1.3 | 2.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.3 | 5.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.3 | 7.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.3 | 2.6 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
1.3 | 3.8 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.3 | 11.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
1.3 | 2.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.3 | 1.3 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
1.3 | 5.0 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.2 | 4.9 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
1.2 | 2.5 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
1.2 | 1.2 | GO:1904395 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.2 | 4.9 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
1.2 | 13.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.2 | 3.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.2 | 3.7 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.2 | 3.7 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.2 | 1.2 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.2 | 3.6 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
1.2 | 2.4 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.2 | 4.8 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
1.2 | 3.6 | GO:0009629 | response to gravity(GO:0009629) |
1.2 | 4.8 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.2 | 1.2 | GO:0060278 | regulation of ovulation(GO:0060278) |
1.2 | 1.2 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
1.2 | 18.0 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.2 | 1.2 | GO:0051593 | response to folic acid(GO:0051593) |
1.2 | 3.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.2 | 7.1 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
1.2 | 1.2 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
1.2 | 2.3 | GO:0050932 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
1.2 | 3.5 | GO:0006868 | glutamine transport(GO:0006868) |
1.2 | 5.9 | GO:0048368 | lateral mesoderm development(GO:0048368) |
1.2 | 4.7 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.2 | 25.6 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
1.2 | 2.3 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
1.1 | 8.0 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
1.1 | 2.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.1 | 3.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.1 | 2.3 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.1 | 2.3 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
1.1 | 3.4 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.1 | 3.4 | GO:0010996 | response to auditory stimulus(GO:0010996) |
1.1 | 4.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.1 | 4.5 | GO:1903012 | positive regulation of bone development(GO:1903012) |
1.1 | 2.2 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
1.1 | 1.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
1.1 | 7.8 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.1 | 2.2 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
1.1 | 2.2 | GO:0060022 | hard palate development(GO:0060022) |
1.1 | 4.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.1 | 2.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.1 | 2.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
1.1 | 3.3 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
1.1 | 3.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.1 | 5.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
1.1 | 3.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.1 | 1.1 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
1.1 | 5.4 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
1.1 | 8.5 | GO:0035418 | protein localization to synapse(GO:0035418) |
1.1 | 2.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
1.1 | 4.3 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
1.1 | 4.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.1 | 3.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.1 | 7.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.1 | 9.5 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
1.1 | 5.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.1 | 1.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
1.0 | 3.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
1.0 | 3.1 | GO:0035106 | operant conditioning(GO:0035106) |
1.0 | 4.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.0 | 18.5 | GO:0001964 | startle response(GO:0001964) |
1.0 | 2.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
1.0 | 2.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.0 | 17.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.0 | 3.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
1.0 | 1.0 | GO:2000851 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
1.0 | 1.0 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.0 | 2.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.0 | 5.9 | GO:0035878 | nail development(GO:0035878) |
1.0 | 4.9 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
1.0 | 64.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.0 | 2.9 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
1.0 | 1.0 | GO:0061055 | myotome development(GO:0061055) |
1.0 | 1.9 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
1.0 | 1.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.0 | 8.7 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.0 | 1.9 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.0 | 1.0 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
1.0 | 2.9 | GO:0015744 | succinate transport(GO:0015744) |
1.0 | 3.8 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
1.0 | 1.9 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.9 | 4.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.9 | 2.8 | GO:0033504 | floor plate development(GO:0033504) |
0.9 | 0.9 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.9 | 2.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.9 | 9.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.9 | 1.9 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.9 | 4.6 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.9 | 17.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.9 | 0.9 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.9 | 3.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.9 | 2.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.9 | 3.5 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.9 | 5.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.9 | 6.1 | GO:0060068 | vagina development(GO:0060068) |
0.9 | 1.7 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.9 | 6.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.9 | 1.7 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.9 | 5.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.9 | 0.9 | GO:0002339 | B cell selection(GO:0002339) |
0.9 | 2.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.8 | 0.8 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.8 | 4.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.8 | 1.7 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.8 | 3.4 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.8 | 4.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.8 | 2.5 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.8 | 1.7 | GO:0060023 | soft palate development(GO:0060023) |
0.8 | 0.8 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.8 | 1.6 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.8 | 2.5 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.8 | 1.6 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.8 | 3.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.8 | 0.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.8 | 1.6 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.8 | 1.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.8 | 0.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.8 | 0.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.8 | 1.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.8 | 0.8 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.8 | 0.8 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.8 | 1.6 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.8 | 7.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.8 | 1.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.8 | 1.6 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.8 | 0.8 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.8 | 16.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.8 | 2.3 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.8 | 2.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.8 | 35.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.8 | 2.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) asymmetric neuroblast division(GO:0055059) |
0.8 | 4.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.8 | 1.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.7 | 1.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.7 | 0.7 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.7 | 3.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.7 | 9.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.7 | 3.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.7 | 3.0 | GO:1990403 | embryonic brain development(GO:1990403) |
0.7 | 1.5 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.7 | 2.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.7 | 2.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.7 | 2.9 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.7 | 8.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.7 | 8.0 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.7 | 1.5 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.7 | 1.5 | GO:0060157 | urinary bladder development(GO:0060157) |
0.7 | 2.2 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.7 | 0.7 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.7 | 2.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.7 | 1.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.7 | 0.7 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.7 | 2.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.7 | 1.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.7 | 0.7 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.7 | 2.1 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.7 | 2.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.7 | 2.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.7 | 2.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.7 | 2.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.7 | 1.4 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.7 | 1.4 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.7 | 1.4 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.7 | 2.8 | GO:0042637 | catagen(GO:0042637) |
0.7 | 5.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.7 | 2.8 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.7 | 0.7 | GO:0072207 | metanephric epithelium development(GO:0072207) |
0.7 | 2.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.7 | 0.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.7 | 6.1 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.7 | 1.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.7 | 4.0 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.7 | 1.3 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.7 | 2.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.7 | 4.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.7 | 1.3 | GO:0030432 | peristalsis(GO:0030432) |
0.7 | 0.7 | GO:0021794 | thalamus development(GO:0021794) |
0.7 | 2.0 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.7 | 2.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.7 | 0.7 | GO:0060437 | lung growth(GO:0060437) |
0.7 | 9.2 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.7 | 2.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.7 | 0.7 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.7 | 3.3 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.7 | 1.3 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.6 | 2.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.6 | 2.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.6 | 1.3 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.6 | 1.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.6 | 2.6 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.6 | 2.6 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.6 | 7.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.6 | 0.6 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.6 | 1.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.6 | 2.5 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.6 | 1.3 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.6 | 4.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.6 | 0.6 | GO:0071280 | cellular response to copper ion(GO:0071280) cellular response to mercury ion(GO:0071288) |
0.6 | 8.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.6 | 1.9 | GO:0003383 | apical constriction(GO:0003383) |
0.6 | 0.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.6 | 1.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.6 | 4.4 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.6 | 1.9 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.6 | 1.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.6 | 1.8 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.6 | 3.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.6 | 0.6 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.6 | 10.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 1.8 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.6 | 1.8 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.6 | 3.6 | GO:0007588 | excretion(GO:0007588) |
0.6 | 1.8 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.6 | 2.4 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.6 | 1.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.6 | 1.8 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.6 | 1.8 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.6 | 1.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.6 | 1.8 | GO:0015755 | fructose transport(GO:0015755) |
0.6 | 7.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.6 | 3.5 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.6 | 1.8 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.6 | 1.2 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.6 | 6.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.6 | 0.6 | GO:0001945 | lymph vessel development(GO:0001945) |
0.6 | 8.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.6 | 2.9 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.6 | 1.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.6 | 2.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.6 | 30.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.6 | 1.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.6 | 1.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.6 | 2.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.6 | 2.2 | GO:0030578 | PML body organization(GO:0030578) |
0.6 | 1.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.6 | 3.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.6 | 1.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.6 | 2.2 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.6 | 1.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.6 | 1.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.5 | 1.6 | GO:0014808 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
0.5 | 2.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.5 | 1.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.5 | 3.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.5 | 1.6 | GO:0015747 | urate transport(GO:0015747) |
0.5 | 1.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.5 | 2.2 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.5 | 1.6 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.5 | 1.6 | GO:0006477 | protein sulfation(GO:0006477) |
0.5 | 0.5 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.5 | 1.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.5 | 5.3 | GO:0035640 | exploration behavior(GO:0035640) |
0.5 | 1.6 | GO:0031296 | B cell costimulation(GO:0031296) |
0.5 | 2.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.5 | 2.1 | GO:0001975 | response to amphetamine(GO:0001975) |
0.5 | 1.6 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.5 | 0.5 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.5 | 2.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.5 | 0.5 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.5 | 5.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.5 | 4.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.5 | 2.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.5 | 5.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.5 | 0.5 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.5 | 1.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.5 | 2.6 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.5 | 0.5 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.5 | 2.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.5 | 1.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.5 | 1.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 2.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.5 | 1.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.5 | 5.6 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.5 | 0.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.5 | 0.5 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.5 | 1.5 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.5 | 12.2 | GO:0008542 | visual learning(GO:0008542) |
0.5 | 3.6 | GO:0021766 | hippocampus development(GO:0021766) |
0.5 | 0.5 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.5 | 0.5 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) regulation of neurotransmitter uptake(GO:0051580) |
0.5 | 4.5 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.5 | 3.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.5 | 2.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.5 | 2.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.5 | 2.9 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.5 | 1.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.5 | 0.5 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.5 | 3.8 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.5 | 0.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.5 | 1.4 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.5 | 3.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.5 | 0.5 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.5 | 1.4 | GO:0043366 | beta selection(GO:0043366) |
0.5 | 2.3 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.5 | 5.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.5 | 1.4 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.5 | 13.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.5 | 0.9 | GO:0021554 | optic nerve development(GO:0021554) |
0.4 | 3.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.4 | 0.9 | GO:0008355 | olfactory learning(GO:0008355) |
0.4 | 1.8 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.4 | 2.2 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.4 | 0.4 | GO:0071599 | otic vesicle development(GO:0071599) |
0.4 | 0.9 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 0.4 | GO:0021756 | striatum development(GO:0021756) |
0.4 | 0.4 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.4 | 3.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.4 | 1.3 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.4 | 1.7 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.4 | 0.9 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.4 | 2.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.4 | 3.8 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.4 | 3.0 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.4 | 39.0 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.4 | 1.3 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.4 | 3.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.4 | 1.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.4 | 2.9 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.4 | 1.3 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.4 | 8.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.4 | 9.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.4 | 0.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.4 | 0.8 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.4 | 1.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.4 | 1.7 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.4 | 6.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.4 | 3.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 0.4 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.4 | 1.2 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.4 | 1.2 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.4 | 1.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.4 | 0.8 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.4 | 0.8 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.4 | 0.8 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.4 | 2.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.4 | 7.2 | GO:0009268 | response to pH(GO:0009268) |
0.4 | 0.4 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.4 | 1.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 4.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.4 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 1.9 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.4 | 2.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.4 | 0.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 0.8 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.4 | 1.1 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.4 | 0.8 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.4 | 0.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 0.4 | GO:0032513 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.4 | 1.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.4 | 3.0 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.4 | 0.4 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.4 | 2.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.4 | 0.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 6.3 | GO:0060325 | face morphogenesis(GO:0060325) |
0.4 | 24.6 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.4 | 0.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.4 | 5.1 | GO:0061245 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.4 | 0.7 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.4 | 0.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.4 | 0.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.4 | 0.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.4 | 1.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 0.7 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.3 | 1.0 | GO:0032058 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translational initiation in response to stress(GO:0032058) |
0.3 | 1.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 1.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 0.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 0.7 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 0.7 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 1.4 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.3 | 2.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.3 | 2.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.3 | 0.7 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.3 | 1.4 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.3 | 0.3 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.3 | 0.7 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.3 | 0.3 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.3 | 1.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 1.7 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.3 | 1.0 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.3 | 1.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 3.3 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.3 | 0.7 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.3 | 0.3 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.3 | 8.4 | GO:0035108 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.3 | 0.6 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.3 | 1.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.3 | 1.6 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.3 | 1.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.3 | 1.0 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 6.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.3 | 0.6 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.3 | 2.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 0.3 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.3 | 0.3 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.3 | 0.6 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 0.3 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.3 | 0.9 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 0.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 0.6 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 0.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 0.3 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.3 | 1.9 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.3 | 0.9 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.3 | 0.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 0.6 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.3 | 1.5 | GO:0007614 | short-term memory(GO:0007614) |
0.3 | 0.9 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.3 | 0.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 8.7 | GO:0003341 | cilium movement(GO:0003341) |
0.3 | 1.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.3 | 1.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 1.8 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.3 | 1.2 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.3 | 3.2 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.3 | 0.6 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.3 | 0.6 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.3 | 0.6 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 1.5 | GO:0044241 | lipid digestion(GO:0044241) |
0.3 | 0.9 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.3 | 2.0 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 0.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.3 | 0.3 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.3 | 3.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.3 | 0.6 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.3 | 0.3 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.3 | 4.8 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 0.6 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.3 | 0.6 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.3 | 0.8 | GO:1903055 | positive regulation of extracellular matrix organization(GO:1903055) |
0.3 | 0.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 3.0 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.3 | 1.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.3 | 1.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 1.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 0.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.3 | 2.4 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.3 | 0.5 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.3 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.5 | GO:0060914 | heart formation(GO:0060914) |
0.3 | 2.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.3 | 0.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 0.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.3 | 0.3 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.3 | 1.9 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.3 | 1.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 1.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.3 | 0.8 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.3 | 0.3 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.3 | 0.5 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.3 | 1.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 8.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.3 | 1.3 | GO:0001553 | luteinization(GO:0001553) |
0.3 | 0.5 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.3 | 0.3 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.3 | 0.5 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.3 | 0.5 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.3 | 0.3 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 1.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.3 | 0.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 1.7 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 2.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.2 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.5 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.2 | 0.7 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 0.5 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 0.5 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.2 | 0.7 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 0.2 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 0.5 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 1.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.9 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.2 | 0.7 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 0.7 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.5 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.2 | 2.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) |
0.2 | 0.7 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body biosynthetic process(GO:0046951) |
0.2 | 1.6 | GO:0001709 | cell fate determination(GO:0001709) |
0.2 | 0.7 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 0.7 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 0.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 2.5 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.2 | 0.7 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.4 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.2 | 0.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.7 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.2 | 0.7 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 2.4 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.2 | 1.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 0.9 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 0.7 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.7 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.2 | 0.4 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.2 | 0.6 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.2 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.2 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.4 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.2 | 2.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.2 | 0.8 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.2 | 0.6 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 0.4 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.2 | 2.5 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.2 | 0.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 1.4 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.6 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 0.4 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 1.2 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 0.8 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 0.2 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.2 | 0.8 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.2 | 0.6 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.8 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 5.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 0.8 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 1.9 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 2.3 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.2 | 0.4 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.2 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 2.4 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.2 | 0.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.2 | 0.6 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 2.0 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 0.7 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 0.5 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 2.0 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.2 | 0.4 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.2 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.2 | GO:0008212 | mineralocorticoid metabolic process(GO:0008212) |
0.2 | 1.2 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.2 | 0.3 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 0.2 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.2 | 3.4 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.2 | 0.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.3 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.2 | 0.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 5.2 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.2 | 0.5 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.5 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.2 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
0.2 | 0.3 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.2 | 2.6 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.2 | 0.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.2 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.2 | 0.3 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.2 | GO:0070268 | cornification(GO:0070268) |
0.2 | 1.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.2 | 3.3 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 0.3 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.2 | 1.6 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.2 | 0.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.2 | 0.3 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.2 | 0.2 | GO:0072182 | regulation of nephron tubule epithelial cell differentiation(GO:0072182) |
0.2 | 0.8 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.2 | 0.8 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 0.3 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 1.7 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.2 | GO:0021988 | olfactory lobe development(GO:0021988) |
0.2 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.2 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.4 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.3 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.4 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 1.3 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 1.9 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.1 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 2.9 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.3 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.4 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.7 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 1.0 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 3.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.5 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 1.3 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 9.9 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.1 | 0.3 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.1 | 0.5 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 2.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.1 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.1 | 0.6 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.1 | 0.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.1 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.2 | GO:0046135 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 1.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.2 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.1 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.2 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.6 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 1.4 | GO:0051875 | pigment granule localization(GO:0051875) |
0.1 | 0.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.5 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 0.1 | GO:0035094 | response to nicotine(GO:0035094) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.1 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.1 | 0.2 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 0.4 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.3 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.3 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.1 | 0.4 | GO:0008306 | associative learning(GO:0008306) |
0.1 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 0.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.3 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.2 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.1 | 0.3 | GO:0051305 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.3 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 1.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.2 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 0.4 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.2 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.7 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.1 | 0.1 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.2 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.1 | 1.1 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.1 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.6 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.7 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.2 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 3.2 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.5 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.3 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 1.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 0.1 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.0 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.0 | 0.1 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.4 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.0 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.2 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.0 | GO:0019230 | proprioception(GO:0019230) |
0.0 | 0.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.1 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.3 | GO:0097479 | synaptic vesicle localization(GO:0097479) |
0.0 | 0.1 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.0 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.0 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.1 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.0 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.0 | GO:0007128 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.0 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.0 | GO:0042938 | dipeptide transport(GO:0042938) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.3 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.0 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 1.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0032196 | transposition(GO:0032196) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.1 | GO:0044393 | microspike(GO:0044393) |
2.8 | 8.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
2.8 | 34.0 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
2.6 | 7.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
2.4 | 9.8 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
2.2 | 2.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
2.2 | 8.7 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
2.2 | 6.5 | GO:0072534 | perineuronal net(GO:0072534) |
2.0 | 8.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
2.0 | 8.1 | GO:0071953 | elastic fiber(GO:0071953) |
1.9 | 23.3 | GO:0043194 | axon initial segment(GO:0043194) |
1.9 | 14.9 | GO:0043083 | synaptic cleft(GO:0043083) |
1.8 | 12.4 | GO:0032584 | growth cone membrane(GO:0032584) |
1.7 | 1.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.7 | 6.7 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.7 | 9.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.6 | 14.3 | GO:0036128 | CatSper complex(GO:0036128) |
1.6 | 15.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.5 | 27.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.5 | 38.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.5 | 19.0 | GO:0034706 | sodium channel complex(GO:0034706) |
1.3 | 5.4 | GO:0016342 | catenin complex(GO:0016342) |
1.3 | 6.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.3 | 2.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.3 | 15.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.2 | 22.2 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.2 | 3.7 | GO:0000322 | storage vacuole(GO:0000322) |
1.2 | 12.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.2 | 13.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.2 | 5.9 | GO:0071547 | piP-body(GO:0071547) |
1.2 | 10.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.2 | 7.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
1.2 | 5.8 | GO:0097255 | R2TP complex(GO:0097255) |
1.1 | 6.8 | GO:0001674 | female germ cell nucleus(GO:0001674) |
1.1 | 68.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.1 | 20.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.1 | 5.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.1 | 1.1 | GO:0097427 | microtubule bundle(GO:0097427) |
1.1 | 8.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.1 | 1.1 | GO:0005818 | aster(GO:0005818) |
1.0 | 8.2 | GO:0036157 | outer dynein arm(GO:0036157) |
1.0 | 2.9 | GO:1990393 | 3M complex(GO:1990393) |
1.0 | 2.9 | GO:0043219 | lateral loop(GO:0043219) |
1.0 | 5.8 | GO:0030673 | axolemma(GO:0030673) |
1.0 | 14.4 | GO:0031045 | dense core granule(GO:0031045) |
0.9 | 7.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.9 | 12.1 | GO:0043196 | varicosity(GO:0043196) |
0.9 | 3.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.9 | 2.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.9 | 2.6 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.9 | 14.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.9 | 26.6 | GO:0005921 | gap junction(GO:0005921) |
0.9 | 3.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.8 | 2.5 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.8 | 3.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.8 | 2.4 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.8 | 7.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.8 | 1.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.8 | 1.6 | GO:1990696 | USH2 complex(GO:1990696) |
0.8 | 3.8 | GO:0043203 | axon hillock(GO:0043203) |
0.8 | 2.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.7 | 0.7 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.7 | 2.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.7 | 4.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.7 | 1.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.7 | 68.7 | GO:0043204 | perikaryon(GO:0043204) |
0.7 | 2.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.7 | 3.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.7 | 3.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.7 | 6.8 | GO:0001527 | microfibril(GO:0001527) |
0.7 | 1.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.7 | 3.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.7 | 2.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.7 | 6.0 | GO:0036156 | inner dynein arm(GO:0036156) |
0.7 | 2.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.7 | 2.0 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.7 | 11.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 1.9 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.6 | 7.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.6 | 6.8 | GO:0030315 | T-tubule(GO:0030315) |
0.6 | 2.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.6 | 9.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.6 | 4.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.6 | 1.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.6 | 16.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.6 | 71.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.6 | 3.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 14.8 | GO:0043198 | dendritic shaft(GO:0043198) |
0.6 | 158.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.6 | 3.5 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.6 | 9.4 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.6 | 20.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.6 | 14.0 | GO:0016235 | aggresome(GO:0016235) |
0.6 | 3.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.5 | 1.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.5 | 2.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.5 | 4.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.5 | 1.6 | GO:0097513 | myosin II filament(GO:0097513) |
0.5 | 0.5 | GO:1990357 | terminal web(GO:1990357) |
0.5 | 2.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.5 | 1.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.5 | 168.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.5 | 12.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 7.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.4 | 3.4 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 3.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.4 | 5.0 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.4 | 4.9 | GO:0043034 | costamere(GO:0043034) |
0.4 | 6.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.4 | 3.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.4 | 1.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 0.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.4 | 1.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.4 | 1.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 0.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 3.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 2.2 | GO:0045179 | apical cortex(GO:0045179) |
0.4 | 1.1 | GO:0000802 | transverse filament(GO:0000802) |
0.4 | 1.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.3 | 13.2 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 19.4 | GO:0043195 | terminal bouton(GO:0043195) |
0.3 | 5.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 5.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.3 | 1.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 2.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 0.3 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 39.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 1.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.3 | 2.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 1.9 | GO:0098793 | presynapse(GO:0098793) |
0.3 | 1.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 0.9 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 0.9 | GO:0097433 | dense body(GO:0097433) |
0.3 | 2.1 | GO:0000800 | lateral element(GO:0000800) |
0.3 | 2.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 9.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 9.4 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.3 | 5.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.3 | 1.1 | GO:1990745 | EARP complex(GO:1990745) |
0.3 | 3.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 0.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 1.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 0.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.3 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
0.3 | 6.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 1.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 1.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 0.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 1.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 3.9 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 0.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 1.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 0.5 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 1.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 1.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 2.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 6.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 1.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 2.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 0.9 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 0.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 1.1 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 1.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.2 | 0.9 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 25.9 | GO:0045177 | apical part of cell(GO:0045177) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 1.1 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 2.4 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 3.4 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 1.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.7 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 1.5 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 1.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 6.4 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 4.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 0.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.5 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 5.0 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 1.7 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.4 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 11.7 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
0.1 | 1.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 2.8 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.6 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 10.6 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 36.6 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.3 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.9 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 1.4 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 3.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.0 | GO:0032010 | phagolysosome(GO:0032010) |
0.0 | 1.5 | GO:0097223 | sperm part(GO:0097223) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 13.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
4.1 | 12.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
3.8 | 23.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
3.6 | 17.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
3.5 | 17.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
3.2 | 9.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
3.2 | 28.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
3.2 | 9.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.1 | 15.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
3.1 | 9.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
3.0 | 14.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
2.9 | 17.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
2.9 | 8.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
2.7 | 10.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.6 | 7.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
2.6 | 18.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.6 | 15.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
2.5 | 10.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
2.3 | 4.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
2.3 | 11.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
2.3 | 2.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
2.3 | 11.3 | GO:0048495 | Roundabout binding(GO:0048495) |
2.2 | 6.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
2.2 | 24.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
2.2 | 24.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
2.2 | 15.2 | GO:0003680 | AT DNA binding(GO:0003680) |
2.1 | 14.7 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
2.1 | 6.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.0 | 41.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.9 | 7.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.8 | 9.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.8 | 5.5 | GO:0035939 | microsatellite binding(GO:0035939) |
1.8 | 3.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.8 | 12.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.8 | 5.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
1.8 | 5.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.8 | 17.7 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
1.8 | 14.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.7 | 15.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.7 | 6.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.7 | 65.1 | GO:0005109 | frizzled binding(GO:0005109) |
1.7 | 5.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.7 | 5.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.7 | 5.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.6 | 3.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.6 | 3.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.6 | 4.8 | GO:0034803 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
1.6 | 18.7 | GO:0031005 | filamin binding(GO:0031005) |
1.6 | 10.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.6 | 3.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.5 | 4.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.5 | 6.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.5 | 7.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.5 | 4.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.5 | 7.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.5 | 8.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
1.5 | 5.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.5 | 11.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.5 | 2.9 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.4 | 1.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.4 | 2.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
1.4 | 12.4 | GO:0038191 | neuropilin binding(GO:0038191) |
1.4 | 4.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.4 | 4.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.3 | 25.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
1.3 | 10.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.3 | 23.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
1.3 | 3.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.3 | 5.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.3 | 15.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.2 | 6.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.2 | 3.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.2 | 11.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
1.1 | 3.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.1 | 3.4 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
1.1 | 3.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.1 | 4.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.1 | 1.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
1.1 | 17.3 | GO:0015026 | coreceptor activity(GO:0015026) |
1.1 | 9.7 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
1.1 | 24.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.1 | 11.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.0 | 3.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.0 | 4.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.0 | 5.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.0 | 18.6 | GO:0005112 | Notch binding(GO:0005112) |
1.0 | 4.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
1.0 | 14.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.0 | 13.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.0 | 3.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.0 | 9.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.0 | 15.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
1.0 | 23.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.0 | 2.9 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.0 | 3.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.0 | 2.9 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
1.0 | 2.9 | GO:0051373 | FATZ binding(GO:0051373) |
1.0 | 1.9 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
1.0 | 4.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
1.0 | 13.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
1.0 | 2.9 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
1.0 | 2.9 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.9 | 2.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.9 | 2.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.9 | 3.7 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.9 | 0.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.9 | 11.9 | GO:0035198 | miRNA binding(GO:0035198) |
0.9 | 4.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.9 | 3.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.9 | 10.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.9 | 27.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.9 | 1.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.9 | 18.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.9 | 15.7 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.9 | 4.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.9 | 0.9 | GO:0005119 | smoothened binding(GO:0005119) |
0.9 | 3.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.9 | 4.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.8 | 3.4 | GO:0070888 | E-box binding(GO:0070888) |
0.8 | 2.5 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.8 | 5.8 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.8 | 3.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.8 | 1.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.8 | 9.9 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.8 | 5.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.8 | 18.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.8 | 20.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.8 | 26.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.8 | 19.9 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.8 | 4.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.8 | 10.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.8 | 7.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.8 | 0.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.8 | 13.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.8 | 5.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.8 | 3.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.8 | 3.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.8 | 30.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.8 | 2.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.8 | 2.3 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.8 | 2.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.7 | 4.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.7 | 5.2 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.7 | 2.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.7 | 9.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.7 | 2.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.7 | 2.8 | GO:0031014 | troponin T binding(GO:0031014) |
0.7 | 6.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.7 | 4.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.7 | 1.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.7 | 2.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.7 | 2.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.7 | 2.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.7 | 0.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.7 | 15.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.6 | 5.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.6 | 3.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.6 | 24.9 | GO:0005267 | potassium channel activity(GO:0005267) |
0.6 | 1.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.6 | 1.8 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.6 | 2.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.6 | 1.8 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.6 | 9.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.6 | 1.8 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.6 | 2.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.6 | 1.8 | GO:0045340 | mercury ion binding(GO:0045340) |
0.6 | 12.6 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.6 | 4.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.6 | 1.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.6 | 14.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.6 | 2.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.6 | 2.9 | GO:1990254 | keratin filament binding(GO:1990254) |
0.6 | 1.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.6 | 0.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 3.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.6 | 2.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.6 | 1.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.6 | 1.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.6 | 4.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.5 | 3.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.5 | 4.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.5 | 122.0 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.5 | 1.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.5 | 1.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.5 | 2.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 4.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 2.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.5 | 18.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.5 | 1.6 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.5 | 1.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.5 | 1.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.5 | 1.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.5 | 2.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.5 | 50.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.5 | 5.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.5 | 0.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.5 | 2.0 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.5 | 2.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.5 | 0.5 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.5 | 2.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.5 | 2.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.5 | 1.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.5 | 1.9 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.5 | 3.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.5 | 0.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.5 | 2.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.5 | 3.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 1.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.5 | 1.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.5 | 12.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.5 | 2.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.5 | 0.9 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.5 | 1.4 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 2.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 4.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 8.2 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.5 | 3.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.4 | 3.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.4 | 3.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.4 | 4.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.4 | 1.8 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.4 | 4.8 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.4 | 2.6 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.4 | 5.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 1.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.4 | 3.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.4 | 15.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.4 | 1.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.4 | 0.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 2.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 0.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.4 | 5.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.4 | 1.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 6.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 3.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.4 | 1.2 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.4 | 1.5 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.4 | 3.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.4 | 0.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.4 | 0.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.4 | 4.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.4 | 4.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.4 | 231.1 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.4 | 10.2 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.4 | 1.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.4 | 1.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 1.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 1.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 1.0 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 0.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 1.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 1.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 2.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 1.9 | GO:0043814 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.3 | 1.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.3 | 1.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 2.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 4.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 5.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 1.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 0.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 1.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 0.9 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.3 | 6.4 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.3 | 2.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 1.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 4.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 1.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 0.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 2.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 0.3 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.3 | 1.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.3 | 0.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 1.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 2.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 1.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.3 | 0.8 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 0.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 1.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 1.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 1.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.3 | 6.7 | GO:0008009 | chemokine activity(GO:0008009) |
0.3 | 0.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.3 | 1.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 0.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 1.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 0.8 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.3 | 2.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.3 | 2.8 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.3 | 3.0 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.2 | 0.2 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.2 | 2.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 1.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.2 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 0.2 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.2 | 6.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 1.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.2 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 96.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 1.4 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 4.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 0.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 0.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.2 | 0.2 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.2 | 0.8 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 1.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 2.0 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 0.6 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.2 | 0.6 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 1.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 2.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 2.1 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 1.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 0.6 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 8.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.2 | 14.7 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 3.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 1.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 0.9 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 1.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 0.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 0.5 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 0.2 | GO:0015927 | trehalase activity(GO:0015927) |
0.2 | 0.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 1.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 2.3 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.2 | 0.2 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.2 | 0.5 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 0.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.8 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.2 | 0.2 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.2 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 0.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 0.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 1.1 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 1.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 1.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 0.3 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 0.9 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 3.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 0.1 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.1 | 2.9 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.9 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.2 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 2.7 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 1.3 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.4 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.1 | 0.3 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 2.6 | GO:0019838 | growth factor binding(GO:0019838) |
0.1 | 0.9 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 0.3 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 1.7 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 1.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 1.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 1.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.3 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.8 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.7 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 1.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.0 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) protein binding involved in cell-matrix adhesion(GO:0098634) |
0.0 | 0.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0030984 | kininogen binding(GO:0030984) |
0.0 | 0.0 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 1.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 6.6 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.2 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 1.0 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 1.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.9 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.0 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.0 | GO:2001069 | glycogen binding(GO:2001069) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 61.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.4 | 1.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.4 | 61.4 | NABA COLLAGENS | Genes encoding collagen proteins |
1.3 | 18.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.2 | 1.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.1 | 3.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.0 | 11.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.9 | 14.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.9 | 1.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.9 | 9.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.8 | 19.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.8 | 20.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.7 | 22.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.7 | 7.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.7 | 110.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.6 | 11.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.6 | 5.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.6 | 18.5 | PID BMP PATHWAY | BMP receptor signaling |
0.6 | 13.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.6 | 18.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.5 | 4.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.5 | 9.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.5 | 127.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.5 | 10.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.4 | 7.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 5.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 8.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 1.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 5.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 1.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 5.8 | PID FGF PATHWAY | FGF signaling pathway |
0.3 | 1.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 6.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 59.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 3.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.3 | 36.8 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.3 | 10.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.3 | 11.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 2.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 6.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 4.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 0.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 8.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 1.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 6.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 4.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.8 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 1.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 31.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
2.6 | 2.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
2.0 | 22.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.8 | 24.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.8 | 24.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.5 | 17.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.5 | 30.8 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
1.5 | 21.8 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.3 | 70.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
1.3 | 18.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.2 | 98.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
1.2 | 37.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.2 | 25.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.2 | 26.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.1 | 49.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.1 | 12.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
1.0 | 8.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.0 | 23.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.0 | 22.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.0 | 15.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.0 | 15.6 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
1.0 | 3.8 | REACTOME GLYCOSAMINOGLYCAN METABOLISM | Genes involved in Glycosaminoglycan metabolism |
1.0 | 21.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.9 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.9 | 9.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.9 | 9.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.9 | 6.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.9 | 6.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.9 | 7.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.8 | 9.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.8 | 16.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.8 | 4.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.7 | 13.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.7 | 0.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.7 | 2.2 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.6 | 5.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.6 | 17.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.6 | 2.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.6 | 8.7 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.6 | 4.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.5 | 5.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.5 | 0.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.5 | 68.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.4 | 5.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 5.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 5.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.4 | 3.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 2.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.4 | 5.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.4 | 8.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.4 | 0.4 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.4 | 6.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 1.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.4 | 3.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.4 | 2.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 1.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 4.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.3 | 0.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 2.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 2.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 5.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 1.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 4.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 3.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 3.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.7 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.4 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.9 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 1.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.7 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |